- Home
- CPRI vs ICUI Comparison
CPRI vs ICUI Comparison
Compare CPRI & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRI
- ICUI
- Stock Information
- Founded
- CPRI 1981
- ICUI 1984
- Country
- CPRI United Kingdom
- ICUI United States
- Employees
- CPRI N/A
- ICUI N/A
- Industry
- CPRI Apparel
- ICUI Medical/Dental Instruments
- Sector
- CPRI Consumer Discretionary
- ICUI Health Care
- Exchange
- CPRI Nasdaq
- ICUI Nasdaq
- Market Cap
- CPRI 3.9B
- ICUI 4.0B
- IPO Year
- CPRI 2011
- ICUI 1992
- Fundamental
- Price
- CPRI $37.83
- ICUI $166.08
- Analyst Decision
- CPRI Buy
- ICUI Buy
- Analyst Count
- CPRI 5
- ICUI 4
- Target Price
- CPRI $40.40
- ICUI $138.33
- AVG Volume (30 Days)
- CPRI 1.5M
- ICUI 228.3K
- Earning Date
- CPRI 11-07-2024
- ICUI 11-04-2024
- Dividend Yield
- CPRI N/A
- ICUI N/A
- EPS Growth
- CPRI N/A
- ICUI N/A
- EPS
- CPRI N/A
- ICUI N/A
- Revenue
- CPRI $5,008,000,000.00
- ICUI $2,304,277,000.00
- Revenue This Year
- CPRI N/A
- ICUI $3.80
- Revenue Next Year
- CPRI $2.21
- ICUI $4.01
- P/E Ratio
- CPRI N/A
- ICUI N/A
- Revenue Growth
- CPRI N/A
- ICUI 0.46
- 52 Week Low
- CPRI $29.28
- ICUI $78.28
- 52 Week High
- CPRI $53.06
- ICUI $167.78
- Technical
- Relative Strength Index (RSI)
- CPRI 68.98
- ICUI 70.18
- Support Level
- CPRI $34.31
- ICUI $160.74
- Resistance Level
- CPRI $36.61
- ICUI $167.78
- Average True Range (ATR)
- CPRI 1.08
- ICUI 4.09
- MACD
- CPRI 0.22
- ICUI -0.88
- Stochastic Oscillator
- CPRI 97.51
- ICUI 87.48
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.